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Background: A tenth of patients with involuntary weight loss (IWL) have gastrointestinal cancer. Ferritin is the first
parameter to be modified during the process leading to iron deficiency anaemia, therefore it should be the most
sensitive. The aim of this study was to assess the ability of ferritin to rule out gastrointestinal cancer in patients with
involuntary weight loss.
Methods: All consecutive patients with IWL admitted in a secondary care university hospital were prospectively
studied. Ferritin, haemoglobin with erythrocyte indices and serum iron were recorded for all patients. The reference
standard was bidirectional endoscopy and/or 6 months follow-up.
Results: 290 patients were included, a quarter had cancer, of which 22 (7.6%) had gastrointestinal cancer (8 gastric
cancer, 1 ileum cancer, 13 colorectal cancer). Ferritin had the best area under the curve (AUC), both for
gastrointestinal cancer (0.746, CI: 0.691-0.794), and colorectal cancer (0.765, CI: 0.713-0.813), compared to the other
parameters of iron deficiency. In the diagnosis of colorectal cancer, ferritin with a cut-off value of 100 mcg/L had a
sensitivity of 93% (CI: 69-100%), and negative likelihood ratio of 0.13, with a negative predictive value of 99%
(96-100%), while for gastrointestinal cancer, the sensitivity was lower (89%, CI: 67-95%), with a negative likelihood
ratio of 0.24. There were three false negative patients, two with gastric cancer, and one with rectal cancer.
Conclusion: In patients with involuntary weight loss, a ferritin above 100mcg/L could rule out colon cancer, but
not gastric or rectal cancer.
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Sensitivity and specificityBackground
Involuntary weight loss (IWL) is an important health
problem, as 3-5% of the patients in internal medicine
departments are admitted for this [1-3], and among
them, a quarter have cancer [4], part of them having
gastrointestinal cancer. For this reason, gastrointestinal
endoscopy is recommended in the diagnosis of IWL,
after the initial investigations consisting in history and* Correspondence: cbaicus@clicknet.ro
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reproduction in any medium, provided the orphysical examination, chest radiography, abdominal
ultrasonography and standard laboratory tests [2,5].
As it is known, iron deficiency anaemia appears in
gastrointestinal cancer due to occult blood loss. However,
anaemia as a diagnostic test for gastrointestinal cancer is
not sensitive, because a high proportion of patients with
gastrointestinal cancer (50%) do not have anaemia at the
moment of tumour diagnosis [6-8].
In the succession of events that leads to iron deficiency
anaemia, ferritin diminution appears early, immediately
after the waning of the iron stores in the bone marrow,
and before occurrence of all the other changes in iron de-
ficiency anaemia: decrease in transferrin saturation, serum
iron, red cell volume and haemoglobin [9], and this allows
us to hope that ferritin would have a higher sensitivity forLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mia is the test with the highest accuracy in the diagnosis
of iron deficiency anaemia compared to the above-
mentioned parameters [10-12].
Serum ferritin was assessed in a few, retrospective stud-
ies for the diagnosis of gastrointestinal cancer, and the
results showed that it has no value as a screening test [13],
probably because it lowers only when the tumour has
grown enough [14], condition that might be satisfied in
the case of IWL [15]. In one study, 10% of the 143 patients
having a ferritin less than 50 mcg/L had gastrointestinal
cancer [16], in two patients without anaemia, a low ferritin
(<18 mcg/L) lead to the discovery of colon cancer [17],
and in 414 patients referred for colonoscopy because of
anaemia, a ferritin higher than 100 mcg/L excluded colo-
rectal cancer [18]. However, in a retrospective study on
359 consecutive elderly inpatients referred to colonoscopy
because of symptoms suggesting colorectal cancer, ferritin
was not useful in the diagnosis [19].
To the date, no studies were done in patients with IWL.
We therefore conducted a diagnostic study to determine
whether ferritin higher than 100 mcg/L is sensitive enough
to exclude gastrointestinal cancer in patients with IWL.
Methods
Setting and patients
We prospectively studied adult patients referred for IWL
(without evident origin after clinical assessment), admit-
ted as inpatients or referred to the day hospital in the
Departments of Internal Medicine of a secondary care
university hospital. All consecutive patients, 18 years of
age or more, were included if they fulfilled one of the
following criteria: 1) documented IWL of at least 5% of
body weight within the last 6 months, or 2) declaration
of a “very much” or “much” concerning the amount of
weight loss, on a Lickert scale with five levels (“very
much”, “much”, “average”, “little” and “not at all”). The
second criterion was applied only for the selection of
patients for whom there was no baseline weight docu-
mentation, and the amount of weight loss could not be
computed in order to fulfil the first criterion; for these
patients, the existence of the weight loss had to be con-
firmed by a relative, or by changes in clothes or belt size.
The patients with voluntary weight loss or with a known
malignancy were not included in the study.
The study was conducted according to the Declaration
of Helsinki, the protocol was approved by the ethics
committee of Colentina University Hospital and all
patients agreed to participate in the study and signed the
informed consent before enrolling.
Study design
The investigative work-up was not standardized; it was
decided by every participating physician, depending onclinical and biological diagnostic clues - therefore only
patients in whom gastrointestinal cancer was suspected
had upper endoscopy and/or colonoscopy. In order to
avoid misclassification concerning the final diagnosis
(gastrointestinal cancer or not) for patients who did not
have endoscopic studies, after leaving the hospital all the
patients were followed up for six months, verifying the
final diagnosis, survival, state of health and further
weight change.
All patients had blood collected at admission. Because
ferritin was measured especially for this study, blood
was centrifuged and the serum was frozen at −70°C; fer-
ritin level was determined later in another laboratory,
therefore the physicians and the endoscopists were
blinded to the results. As one of the objectives of the re-
search project was the validation of several simple clin-
ical and biological parameters, found as diagnostic for
cancer in IWL patients in three previous studies [20-22],
all patients had a complete blood cell count (including
MCV and RDW) and determination of blood erythrocyte
sedimentation rate (ESR), serum C reactive protein
(CRP), iron, albumin, alkaline phosphatase (ALP), alanin
aminotranspherase (ALAT) and lactate dehydrogenase
(LDH) levels, determined in the hospital laboratory. All
variables were first recorded by every physician in a pre-
formed questionnaire, and then registered by one of the
authors into the database.
Laboratory procedures
The RDW, haemoglobin level and MCV were deter-
mined using the Sysmex XT 1800i counter (Sysmex Cor-
poration, Kobe, Japan). Ferritin was measured with
Chemwell 2910 analyzer (Awareness Technology, Palm
City, Florida, USA), while serum albumin, iron, ALP,
ALAT, LDH and CRP levels were measured using the
Cobas 6000 Modular P 800 analyzer (Roche Diagnostics,
Rotkreuz, Switzerland). ESR was measured by Wester-
green method. Throughout the study, the quality of
results was validated by regular internal quality control
procedures and participation in an external quality as-
sessment scheme.
Statistical analysis
The outcomes were gastrointestinal cancer/colorectal
cancer as a cause of IWL, while the predictor variable
was ferritin.
Results were expressed as frequencies for categorical
variables, and median and extremes for non normal con-
tinuous variables. Stata 11 (StataCorp, College Station,
Texas, USA) was used for the database construction and
data analysis (area under the curve calculation with con-
fidence intervals, and logistic regression). Hypothesis
testing was 2-tailed, with P < .05 considered statistically
significant. EBM calculator 1.0 (www.cebm.utoronto.ca)
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predictive values and likelihood ratios.
Results
Patients: inclusion, work-up and follow-up
292 consecutive patients with IWL were admitted from
January 2009 to September 2010 (flow diagram pre-
sented in Figure 1). Two patients refused to participate,
therefore 290 patients were included in the present
study – 228 fulfilled the first inclusion criterion (baseline
weight was known, so the amount of weight loss could
be computed), while the other 62 fulfilled the second
criterion.
All admitted patients had hospital work-up and deter-
mination of ferritin. 279 (96%) patients had the reference
standard (bidirectional endoscopy and/or 6 months
follow-up of which 140 patients had bidirectional endos-
copy), while 11 patients did not have endoscopy and
were lost to follow-up after leaving the hospital: four
were diagnosed with cancer, other than gastrointestinal
(two by histopathology, and two by a combination of20 had only endoscopy
- 2 gastric cancers
128  had both endos
and 6 months follow-
- 6 gastric canc
12 colorectal c
- 1 ileal cancer
292 eligible patients with IWL
2 refused to participate
290 patients with IWL included
(228 fulfilled 1st criterion
62 fulfilled 2nd criterion)
All 290 had work-up for IWL etiology
279 had reference standard
(bidirectional endoscopy and/or 6 month follow-u
11 patients without endos
lost to follow-up
- 4 diagnosed with ca
gastrointestinal) (2
CT & tumoral mark
- 7 without cancer (2
depression, 1 polya
290 patients had hemoglobin, 
MCV, RDW, ferritin measured
236 had serum iron measured
Figure 1 Flow diagram of the study.computed tomography and elevated serum tumour mar-
kers), while the other seven patients left the hospital
without a cancer diagnosis (two were diagnosed with
hyperthyroidism, four with depression, and 1 with poly-
artheritis nodosa). The eight patients diagnosed with
gastric cancer had only upper endoscopy, considering
this cancer as the cause of their weight loss, therefore
the colonoscopy was not performed; of these patients, 6
were followed-up for six months.
The characteristics of the patients, together with the
results of the haematological and inflammation tests (in-
cluding ferritin) are provided in Table 1.
Outcome
22 patients were diagnosed with gastrointestinal cancers
(7.6%) (8 gastric cancers, 1 ileum cancer, 10 colonic can-
cers and 3 rectal cancers). 148 patients (51%) had upper
endoscopy, and 140 patients (48%) had colonoscopy
performed.
As seen in Table 2, ferritin had the best area under the
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Age (yr) 67 (22, 94) 70 (55, 82) 66 (44, 93)
Male sex 104 (48%) 12 (54%) 30 (58%)
RDW (%) 14.5 (10.3, 26.7) 14.8 (12.3, 20.4) 15.1 (11.5, 20.8)
Haemoglobin (g/dL) 12.6 (6.14, 17.4) 11.3 (7.9, 15.1) 11.8 (5.42, 17.7)
MCV (fL) 88 (62, 124) 84.5 (64, 98) 88.2 (72, 102)
Serum iron (mcg/dL) 54 (10, 197) 35.5 (10, 118) 35 (4, 162)
Ferritin
(mcg/L)
99.5 (3, 2000) 26.5 (10, 500) 226 (15, 1105)
ESR (mm/h) 28 (2, 140) 44.5 (3, 140) 58 (11, 140)
CRP (mg/L) 5 (0.51, 328) 22 (1.6, 125) 46 (1, 550)
ALAT (u/L) 18 (6, 325) 18 (10, 71) 26 (10, 143)
Total number 216 22 52
Table 3 Ferritin with cut-off values of 100 mcg/L and
50 mcg/L, and anaemia in the diagnosis of







Sensitivity (%) 86 (67–95) 93 (69–100)
Specificity (%) 57 (51–62) 56 (50–62)
Positive predictive
value (%)
14 (9–21) 10 (6–16)
Negative predictive
value (%)
98 (94–100) 99 (96–100)
Positive likelihood ratio 2 2.1
Negative likelihood ratio 0.24 0.13
Sensitivity (%) 59 (39–77) 64 (39–84)








96 (92–98) 98 (95–99)
Positive likelihood ratio 2.5 2.6
Negative likelihood ratio 0.54 0.47
Sensitivity (%) 68 (47–84) 64 (39–84)
Specificity (%) 51 (45–57) 50 (44–56)
Anaemia Positive predictive
value (%)
10 (6–16) 6 (3–11)
Negative predictive
value (%)
95 (90–98) 97 (92–99)
Positive likelihood ratio 1.4 1.3
Negative likelihood ratio 0.63 0.71
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0.813), while haemoglobin, mean red cell volume (MCV)
and serum iron performed worse; red cell distribution
width (RDW) was not useful.
For a cut-off value of 100 mcg/L, ferritin had a sensi-
tivity of 93% (CI: 69-100%) for colorectal cancer, with a
negative likelihood ratio of 0.13, and a negative predict-
ive value of 99% (CI: 96-100%), for a prevalence of 5%
(Table 3). The parameters were lower when gastrointes-
tinal cancer was considered instead of colorectal cancer.
In the same table there are presented the parameters for
a ferritin cut-off value of 50 mcg/L and anaemia as diag-
nostic tests for colorectal and gastrointestinal cancer
(anaemia was defined using theWorld Health Organization
definitionof haemoglobin less than13g/dL formen, and less
than12g/dLforwomen)[23].
In a multivariable model where the haematological para-
meters, together with age and sex were entered, only fer-
ritin was associated with gastrointestinal and colorectal
cancer (Table 4): after controlling for age, sex, haemoglo-
bin, serum iron and red cell indices, patients with ferritin
<100 mcg/L were 7 times more likely to have gastrointes-
tinal cancer and 11 times more likely to have colorectalTable 2 Areas under the curve for ferritin, MCV, serum
iron, haemoglobin and RDW in the diagnosis of
gastrointestinal cancer
Gastrointestinal cancer Colorectal cancer
AUC (95% CI) AUC (95% CI)
Ferritin 0.746 (0.691-0.794) 0.765 (0.713-0.813)
MCV 0.627 (0.568-0.684) 0.669 (0.612-0.725)
Serum iron 0.636 (0.571-0.697) 0.650 (0.584-0.710)
Haemoglobin 0.590 (0.530-0.646) 0.552 (0.491-0.609)
RDW 0.541 (0.476-0.602) 0.463 (0.401-0.528)cancer. The results were not changed when ESR, CRP and
ALAT were introduced into the model in order to evalu-
ate the influence of inflammation and alcohol consump-
tion (Additional file 1). In bivariate analysis, we found that
ferritin was statistically associated to serum inflammatory
markers and alcohol consumption, although the associ-
ation was weak (Kendall’s r = 0.252 with ESR, 0.279 with
CRP and 0.235 with ALAT, p < 0.001).
Ferritin was statistically associated with gastrointes-
tinal/colorectal cancer only in patients with anaemia,
and areas under the curve performed better in these
patients than in the whole sample (AUC = 0.799, CI:
0.688-0.910 for gastrointestinal cancer, and 0.839, CI:
0.765-0.913 for colorectal cancer) (Table 5).Discussion
Endoscopic investigations (both upper and lower) are
recommended immediately after history, physical examin-
ation, chest radiography, abdominal ultrasonography and
standard laboratory tests in patients with IWL [2,5], be-
cause gastrointestinal cancer is always feared, although its
frequency is about 10% in patients with IWL [5,15,20]. In
Table 4 Haematological parameters, together with age
and sex, as predictors of colorectal/gastrointestinal
cancer in patients with IWL – logistic regression
Variable Odds ratio 95% CI P value
Colorectal sex (male) 1.18 0.26, 5.36 0.824
cancer age (years) 1.08 0.99, 1.17 0.053
(14 patients) hemoglobin (g/dl) 0.84 0.53, 1.34 0.473
MCV (femtoliters) 0.87 0.76, 0.99 0.049
serum iron (mcg/dl) 0.99 0.96, 1.02 0.601
RDW (%) 0.70 0.43, 1.13 0.148
ferritin < 100 mcg/L 11.57 1.34, 99.21 0.026
Gastrointestinal sex (male) 1.54 0.51, 4.68 0.443
cancer age (years) 1.05 0.99, 1.10 0.060
(22 patients) hemoglobin (g/dl) 0.86 0.64, 1.51 0.310
MCV (femtoliters) 0.97 0.89, 0.05 0.441
serum iron (mcg/dl) 0.99 0.97, 1.01 0.392
RDW (%) 0.98 0.74, 1.31 0.906
ferritin < 100 mcg/L 6.96 1.84, 26.27 0.004
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gated using upper endoscopy, and 140 patients (48%) had
colonoscopy, while the frequency of gastric and colorectal
cancer was only 2.8% and 4.5%, respectively.
Generally, the sensitivity of anaemia for the diagnosis
of gastrointestinal cancer is only about 50% [6-8], but
theoretically it should be more sensitive in IWL, as more
advanced tumours are usually diagnosed in these
patients [15]. On the other hand, ferritin should be more
sensitive in the diagnosis of iron deficiency states, there-
fore in the diagnosis of gastrointestinal cancer as the






Ferritin P < 0.001
(100mcg/L)
Ferritin P < 0.001
(50 mcg/L)





Ferritin (100mcg/L) P = 0.125
Ferritin
P = 0.196(50 mcg/L)
Ferritin (mcg/L) P = 0.536
* Fisher’s exact test.
† Mann–Whitney U test.Ferritin was assessed in a few studies for the diagnosis of
gastrointestinal cancer, and revealed that 10% of 143
patients with a ferritin less than 50 mcg/L had gastrointes-
tinal cancer [16]; in two patients without anaemia, a low
ferritin (<18 mcg/L) actually lead to the discovery of colon
cancer [17]; and in 414 patients referred for colonoscopy
because of anaemia, a ferritin higher than 100 mcg/L
excluded colorectal cancer [18]. However, in a retrospect-
ive study on 359 consecutive elderly inpatients referred to
colonoscopy because of symptoms suggesting colorectal
cancer, ferritin was not useful in the diagnosis [19].
In the current study, we examined the usefulness of
ferritin in the diagnosis of gastrointestinal/colorectal
cancer in patients with IWL, and we found that ferritin
was a better test than serum iron, MCV, haemoglobin,
and RDW, as it had the biggest AUC, and it was the only
test associated with gastrointestinal and colorectal can-
cer in multivariable analysis.
Ferritin ≥ 100 mcg/L could exclude colon cancer, because
it had good sensitivity and negative likelihood ratio, and a
very high negative predictive value. The main weakness of
the study is the low prevalence of colon cancer in this series
of patients with IWL, possibly overestimating the negative
predictive value of ferritin ≥ 100 mcg/L, and leading to a
relatively large confidence interval for the sensitivity.
The cut-off value of 50 mcg/L for ferritin is useless,
because the test looses sensitivity, without a decisive
gain in specificity, while anaemia is, as expected, a little
more sensitive for gastrointestinal cancer in these
patients with IWL than in other patients, but not sensi-
tive enough to rule out the disease.
Ferritin < 100 mcg/L was less sensitive for gastrointes-
tinal cancer, because of two false negative gastric can-
cers, the third false negative being a rectal cancer. Uponents with and without anemia
trointestinal cancer Colorectal cancer
AUC (95%CI) AUC (95%CI)
* P < 0.001*
* P = 0.005*
† 0.799 P < 0.001† 0.839
(0.713-0.813) (0.765-0.913)
* P = 0.375*
* P = 0.154*
† 0.663 P = 1.000† 0.635
(0.468-0.859) (0.391-0.880)
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very sensitive only for colon cancer, whose main feature
is iron deficiency anaemia, and not for the extremities of
the digestive tract (stomach and rectum), which are, any-
way, easier to explore by upper endoscopy and recto-
scopy (Additional file 2).
Ferritin as a diagnostic test performed much better
than haemoglobin both in terms of AUC and sensitivity.
Using ferritin in place of haemoglobin, 6 additional
patients without anaemia were diagnosed with cancer (1
with caecum cancer, 2 with stomach cancer, 2 with rectal
cancer, and one with sigmoid cancer) (Table 6).
The fact that ferritin was not associated with gastro-
intestinal/colon cancer in patients without anaemia was
unexpected. This finding could be explained, in our opin-
ion, by the low statistical power (only 7 and 5 patients
without anaemia had gastrointestinal and colon cancer, re-
spectively), and by the fact that, in this population with
IWL, ferritin was more homogenous in patients without
anaemia, who generally did not have an organic disease,
while being more frequently elevated in patients withTable 6 Ferritin, ESR, CRP, ALAT and alcoholism* in
patients with gastrointestinal cancer
Localisation
of cancer
nr Ferritin Anaemia ESR PCR ALAT Alcoholism
CAECUM 1 38 NO 16 5.7 12.7 NO
COLON
1 71 YES 101 77.4 13 NO(ascending,
2 82 YES 140 125 30 NOtransverse,
3 26 YES 57 25.6 21.7 NO
descending)
4 10 YES 60 1.7 12 NO
5 20 YES 71 53 12 NO
6 14 YES 44 29.6 14.6 NO
7 17 YES 45 22 34 YES
STOMACH 1 16 NO 10 1.59 15 NO
2 87 YES 53 110 47 YES
3 12 YES 44 40 24 NO
4 108 YES 29 26.5 71 YES
5 15 YES 24 18.7 24 NO
6 500 YES 90 51 30 NO
7 86 NO 36 21.7 18 NO
8 11 YES 40 20.7 10 NO
ILEUM 1 58 YES 49 35 NO
RECTUM 1 27 NO 51 36.5 13 NO
2 322 NO 56 27 31 NO
3 18 NO 3 7.3 19 NO
SIGMOID 1 23 YES 16 16 10 NO
2 83 NO 18 3 10.4 NO
* alcoholism as discharge diagnosis.anaemia of chronic disease, or low in patients with iron
deficiency anaemia due to gastrointestinal cancer [24].
As it is known, ferritin increases in inflammation and
alcohol consumption, which means that, if adjusted for
inflammation, this test could have become even better as
sensitivity (with fewer false negatives), and therefore for
ruling out the disease. However, there are no guidelines
concerning this adjustment: one source suggests that in-
flammation augments the serum ferritin threefold, and
therefore its value should be divided by three [9], with-
out any research study as reference, while a meta-
analysis showed that inflammation augments the value
of ferritin with about 40% [25], but it is based mainly on
studies on children with acute inflammation. Nowhere is
stated from what level of inflammation one should ad-
just, and if adjustment should be the same for a CRP of
10 as for a CRP of 80 mg/L. This eventual adjustment
could have changed the classification of only 3 patients
with ferritin higher than 100mcg/L who tested false
negatives (two with stomach cancer and one with rectal
cancer (Table 6), but it is probably that the patient with
stomach cancer and ferritin of 500 mcg/L would have
been a false negative regardless of any such adjustment,
because even if divided by three, the value still would
have been higher than 100 mcg/L.
Because IWL can have multiple causes, it is difficult, ex-
pansive and frequently useless to settle a standardized in-
vestigation protocol [2]. We decided to let the investigators
decide the diagnostic approach in every patient, depending
on clinical and biological diagnostic clues. In order to avoid
misclassification concerning the final diagnosis (gastrointes-
tinal cancer or not) for patients who did not have both
upper and lower digestive endoscopy, after leaving the hos-
pital the patients were followed up for six months, therefore
our diagnostic study had a valuable reference standard.
Only 11 (3.8%) patients did not have endoscopy and were
lost to follow-up after leaving the hospital, of which only 4
had not a certain cause for their weight loss. All patients
had ferritin measured.Conclusions
Our study demonstrates that, in patients with involun-
tary weight loss, a ferritin above 100mcg/L could rule
out colon cancer, but not gastric or rectal cancer.Additional files
Additional file 1: Table 4. Haematological parameters, adjusted for age,
sex, inflammation and alanin aminotranspherase (as a surrogate for
alcohol consumption) as predictors of colorectal/gastrointestinal cancer
in patients with IWL – logistic regression.
Additional file 2: Figure 2. The mean value of ferritin (mcg/L) in
different locations of gastrointestinal tract cancers (colon = ascending,
transverse and descending colon).
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